Prospect: information for the patient
Modafinilo Viatris 100mg tablets EFG
Read this prospect carefully before starting to take this medication, as it contains important information for you.
1.What is Modafinilo Viatrisand for what it is used
2.What you need to know before starting to take Modafinilo Viatris
3.How to take Modafinilo Viatris
4.Adverse effects
5.Storage of Modafinilo Viatris
6.Contents of the package and additional information
The active ingredient in the tablets is modafinilo. Modafinilo can be used by adults who suffer from narcolepsy to help them stay awake. Narcolepsy is a condition that causes excessive daytime sleepiness and a tendency to fall asleep suddenly in inappropriate situations (sleep attacks).
Modafinilo may improve narcolepsy and reduce the likelihood of sleep attacks, although there may be other ways to improve your condition, and your doctor will inform you of them.
Do not take Modafinilo Viatris:
Warnings and Precautions
Consult your doctor or pharmacist before starting to take Modafinilo Viatris:
Other aspects to discuss with your doctor or pharmacist
During treatment
Consult your doctor or pharmacist:
These may be symptoms of a potentially life-threatening multi-organ hypersensitivity reaction.
Children and adolescents
Children under 18 years old should not take this medication.
Other medications and Modafinilo Viatris
Inform your doctor or pharmacist if you are taking, have taken recently or may need to take any other medication, including those purchased without a prescription. Modafinilo Viatris and other medications may affect each other, and your doctor may need to adjust the doses you are taking.
It is especially important if you are taking any of the following medications with Modafinilo Viatris:
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, or think you may be pregnant, do not take this medication.
Modafinilo is suspected to cause congenital defects if taken during pregnancy.
Consult your doctor about suitable birth control methods for you while you are on treatment with modafinilo (and for two months after stopping it) or if you have any other questions.
Do not take this medication if you are breastfeeding, as it may pass into breast milk.
Driving and operating machinery
Modafinilo Viatris may cause blurred vision or dizziness in 1 in 10 patients.
If you experience any of these effects or still feel drowsy while taking this medication, avoid driving vehicles or operating machinery.
Modafinilo Viatris contains lactose.
If your doctor has told you that you have a certain sugar intolerance, contact them before taking this medication.
Modafinilo Viatris contains sodium.
This medication contains less than 1mmol of sodium (23mg) per tablet, which is essentially “sodium-free”.
Follow exactly the administration instructions for this medication as indicated by your doctor. In case of doubt, consult your doctor or pharmacist again. The tablets should be swallowed whole with a little water.
Adults
The recommended dose is 200 mg per day. It can be taken once a day (in the morning) or divided into two doses per day (100 mg in the morning and 100 mg at noon). In certain cases, your doctor may decide to increase your daily dose up to 400 mg.
Older adults (age 65 years and older)
The recommended dose is 100 mg per day.
Your doctor will only increase your daily dose (up to a maximum of 400 mg per day) if you do not have severe liver or kidney problems.
Adults with severe liver problems
The recommended dose is 100 mg per day.
Your doctor will regularly review your treatment to check that it is suitable for you.
The tablets should be swallowed whole with a little water.
If you take more Modafinilo Viatris than you should
If you have taken too many tablets, you may feel unwell, restless, disoriented, confused, agitated, anxious, or excited. You may also experience difficulty sleeping, diarrhea, hallucinations (hearing, seeing, or feeling things that are not real), chest pain, a change in the speed of your heartbeats, or an increase in your blood pressure. Contact the emergency department of the nearest hospital or consult your doctor or pharmacist immediately.
Carry this leaflet and the rest of the tablets with you.
If you forget to take Modafinilo Viatris
If you forget to take your medication, take the next dose at the usual time. Do not take a double dose to make up for the missed doses.
If you have any other questions about the use of this medication, ask your doctor or pharmacist.
Like all medicines, this medicine may cause side effects, although not everyone will experience them.
Stop taking this medicine and immediately inform your doctor if:
Other side effects include the following:
Very common side effects(may affect more than 1 in 10 people):
Common side effects(may affect up to 1 in 10 people):
Uncommon side effects(may affect up to 1 in 100 people):
Reporting side effects
If you experience side effects, consult your doctor or pharmacist, even if they do not appear in this leaflet. You can also report side effects directly throughthe Spanish System for Pharmacovigilance of Medicines for Human Use: https://www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medicine.
Keep this medication out of the sight and reach of children
Do not take this medication after the expiration date that appears on the outer packaging and the blister pack after CAD. The expiration date is the last day of the month indicated.
This medication does not require special storage conditions.
Medications should not be disposed of through drains or trash. Dispose of the packaging and medications you no longer need at the SIGRE collection point at the pharmacy. If in doubt, ask your pharmacist how to dispose of the packaging and medications you no longer need. By doing so, you will help protect the environment.
Composition of Modafinilo Viatris
The active ingredient is modafinilo.
Each Modafinilo Viatris 100 mg tablet contains 100 mg of modafinilo.
The other components are: lactose (see section 2 "Modafinilo Viatris contains lactose"), croscarmelosa sódica, povidona, and estearato de magnesio.
Appearance of Modafinilo Viatris and packaging contents
Modafinilo Viatris 100 mg tablets
White or off-white, capsule-shaped tablets, approximately 12.6 mm × 5.5 mm in size, marked with a "41" on one face and a "J" on the other. Available in blister packs of aluminio of PVC/PVdC of 30, 60, or 90 tablets and plastic bottles of 30 and 100 tablets. The bottles contain a desiccant; do not ingest the desiccant.
Only some packaging sizes may be marketed.
Marketing authorization holder and responsible manufacturer
Marketing authorization holder
Viatris Limited
Damastown Industrial Park
Mulhuddart, Dublin 15
Dublin
Ireland
Responsible manufacturer
McDermott Laboratories Limited t/a Gerard Laboratories t/a Mylan Dublin
Unit 35/36 Baldoyle Industrial Estate,
Grange Road, Dublin 13
Ireland
or
Mylan Hungary Kft.
Mylan utca 1.
Komárom, H-2900
Hungary
You can request more information about this medication by contacting the local representative of the marketing authorization holder:
Viatris Pharmaceuticals, S.L.U.
C/ General Aranaz, 86
28027 - Madrid
Spain
This medication is authorized in the member states of the European Economic Area with the following names:
United Kingdom | Modafinil 100 mg Tablets |
Spain | Modafinilo Viatris 100 mg comprimidos EFG |
France | Modafinil Mylan |
Sweden | Myldamo |
Denmark | Myldamo |
Iceland | Myldamo |
Last review date of this leaflet:September 2020
More detailed and up-to-date information about this medication is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS)http://www.aemps.gob.es/
Have questions about this medication or your symptoms? Connect with a licensed doctor for guidance and personalized care.